Security key
02043Q107
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY)
CUSIP: 02043Q107
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 133,131,695
- Total 13F shares
- 113,477,846
- Share change
- -168,206
- Total reported value
- $16,543,858,767
- Put/Call ratio
- 62%
- Price per share
- $145.85
- Number of holders
- 405
- Value change
- -$67,066,647
- Number of buys
- 176
- Number of sells
- 217
Report period
Q2 2022
Institutions
405
Top holders
10
ALNY full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
ALNYLAM PHARMACEUTICALS, INC. SEC filings
ALNYLAM PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 02043Q107
Recent filing periods:
Top shareholders of ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
12%
|
16,045,316
|
$2,620,040,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.1%
|
10,829,144
|
$1,768,291,000 | — | 31 Mar 2022 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
7.6%
|
10,139,729
|
$1,655,716,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.7%
|
7,608,954
|
$1,242,466,000 | — | 31 Mar 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.3%
|
7,034,487
|
$1,148,660,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
5.1%
|
6,794,166
|
$1,109,419,000 | — | 31 Mar 2022 | |
| Capital World Investors |
13F
|
Company |
4.5%
|
5,999,674
|
$979,687,000 | — | 31 Mar 2022 | |
| DODGE & COX |
13F
|
Company |
4.1%
|
5,475,668
|
$894,122,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.2%
|
2,919,015
|
$476,646,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
2,909,490
|
$475,091,000 | — | 31 Mar 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
1.3%
|
1,751,063
|
$286,056,679 | — | 31 Mar 2022 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.3%
|
1,683,362
|
$274,876,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,570,283
|
$256,023,000 | — | 31 Mar 2022 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.98%
|
1,300,000
|
$212,277,000 | — | 31 Mar 2022 | |
| NORGES BANK |
13F
|
Company |
0.97%
|
1,295,087
|
$211,474,756 | — | 31 Mar 2022 | |
| Bellevue Group AG |
13F
|
Company |
0.92%
|
1,229,563
|
$200,776,000 | — | 31 Mar 2022 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.85%
|
1,131,844
|
$184,819,000 | — | 31 Mar 2022 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.77%
|
1,023,873
|
$167,188,000 | — | 31 Mar 2022 | |
| Casdin Capital, LLC |
13F
|
Company |
0.75%
|
1,000,000
|
$163,290,000 | — | 31 Mar 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.73%
|
968,755
|
$158,187,000 | — | 31 Mar 2022 | |
| Amundi |
13F
|
Individual |
0.66%
|
874,950
|
$141,958,000 | — | 31 Mar 2022 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.65%
|
868,748
|
$141,858,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.64%
|
848,656
|
$138,578,000 | — | 31 Mar 2022 | |
| Holocene Advisors, LP |
13F
|
Company |
0.6%
|
799,222
|
$130,505,000 | — | 31 Mar 2022 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.59%
|
791,224
|
$129,199,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.57%
|
763,340
|
$124,646,000 | — | 31 Mar 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0.57%
|
757,422
|
$123,680,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.51%
|
681,553
|
$111,290,000 | — | 31 Mar 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.5%
|
660,940
|
$107,925,000 | — | 31 Mar 2022 | |
| Artal Group S.A. |
13F
|
Company |
0.49%
|
650,000
|
$106,139,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.48%
|
638,867
|
$104,321,000 | — | 31 Mar 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.45%
|
605,165
|
$98,817,395 | — | 31 Mar 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.45%
|
598,448
|
$97,724,000 | — | 31 Mar 2022 | |
| Swiss National Bank |
13F
|
Company |
0.39%
|
518,010
|
$84,586,000 | — | 31 Mar 2022 | |
| Blackstone Inc. |
13F
|
Company |
0.39%
|
517,391
|
$84,485,000 | — | 31 Mar 2022 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.35%
|
468,452
|
$76,494,000 | — | 31 Mar 2022 | |
| Deep Track Capital, LP |
13F
|
Company |
0.35%
|
463,663
|
$75,712,000 | — | 31 Mar 2022 | |
| Swedbank AB |
13F
|
Company |
0.33%
|
438,356
|
$71,579,151 | — | 31 Mar 2022 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.3%
|
402,652
|
$65,749,000 | — | 31 Mar 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.29%
|
392,682
|
$64,121,000 | — | 31 Mar 2022 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.28%
|
373,964
|
$61,062,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.28%
|
372,623
|
$60,846,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.27%
|
362,035
|
$58,806,000 | — | 31 Mar 2022 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.25%
|
332,500
|
$54,294,000 | — | 31 Mar 2022 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.24%
|
322,743
|
$52,701,000 | — | 31 Mar 2022 | |
| EATON VANCE MANAGEMENT |
13F
|
Company |
0.23%
|
306,228
|
$50,005,000 | — | 31 Mar 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.23%
|
303,653
|
$49,581,000 | — | 31 Mar 2022 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.23%
|
302,743
|
$49,434,000 | — | 31 Mar 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.21%
|
282,110
|
$46,066,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.21%
|
277,257
|
$45,273,000 | — | 31 Mar 2022 |
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) as of Q2 2022
As of 30 Jun 2022,
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) was held by
405 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
113,477,846 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, Capital World Investors, BAILLIE GIFFORD & CO, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, Dodge & Cox, STATE STREET CORP, and JPMORGAN CHASE & CO.
This page lists
406
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
417
Q2 2022 holders
405
Holder diff
-12
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.